Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novartis and smartpatient launch app experience for wet AMD patients

Wet AMD is the leading cause of severe vision loss and legal blindness in people over the age of 65

Novartis and smartpatient have launched a new educational app experience for patients with age-related wet macular degeneration (AMD).

The ‘See What’s Next’ section of the MyTherapy app, co-created by Novartis and smartpatient, provides wet AMD patients and their caregivers with resources, as well as educational tools.

The app section is designed to encourage people living with this condition to improve their treatment adherence, which is crucial to reducing the risk of vision loss.

It also supports patients and caregivers in arranging appointments, digitally connecting them through the app experience.

“Non-adherence is a challenge in most health conditions, but in few are consequences as direct and severe as in wet AMD,” says Sebastian Gaede, chief executive officer of smartpatient.

“I was truly impressed seeing Novartis and us working as one team, with every single team member highly motivated by our shared goal of supporting patients in avoiding complications and reducing the risk of vision loss,” he added.

Wet AMD is the leading cause of severe vision loss and legal blindness in people over the age of 65 in the US, Europe, Australia and Asia.

Early symptoms include distorted vision and as the disease progresses, cell damage increases, resulting in further reduction in vision quality.

On top of using the ‘See What’s Next’ section, users can use the MyTherapy app for managing other health conditions and medications.

The ‘See What’s Next’ section of the MyTherapy app first launches in Italy and Spain, with patients and caregivers receiving access to the app via their treating ophthalmologist.

In the future, Novartis and smartpatient also plan to roll the wet AMD section out to further markets.

Article by
Lucy Parsons

19th November 2020

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...

Infographics